...and Majikthise has one of the most interesting comments about it.
. . . The real question is why Merck acted so precipitously? Vioxx was one of their best selling drugs. I think it's because they're afraid of lawsuits. Merck has know about the CV risk of Vioxx for years. I wonder why these particular data finally convinced them to pull the drug.
Corporations aren't evil, but they are organized solely for maximizing profit. Without effective regulation, and without the public's ability to hold them liable for destructive behavior, they will cause a great deal of harm.
EDIT: For some more interesting comments, see Chris Rangel:
So we lose an overly marketed drug that was no more effective and much more expensive than other NSAIDs and had few if any advantages (once a day dosing if that is worth the price). Big deal. But now we are likely to see act II of this drama entitled: "Class Action attack of the Trial Lawyers". Even though the relative increase in cardiovascular events was 50%, the absolute increase was tiny, well under 1% for the study population of 8,000. However, this doesn't matter to greedy trial lawyers and their equally greedy and paranoid clients.Posted by Carey at October 1, 2004 10:05 AM
While I take Rangel's comments to heart, it somehow seems to me that if someone produces a drug that has no greater efficacy and yet increases cardiovascular problems, for even a small number of people, they should have to bear the costs of their decision.
Yeah, there's greed there -- but it's on both sides, and I don't see why a patient who has been hurt by a drug should say, "well, this greedy pharmaceutical company hurt me, so I'll just suck it up."
Posted by: Heidi at October 2, 2004 08:53 AMTest?
Posted by: Heidi at October 2, 2004 09:16 PM